ASCO 2015 | Advances in the treatment of CLL at ASCO 2015

Stephan Stilgenbauer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Stephan Stilgenbauer, MD, of Ulm University, Ulm, Germany, reviews the changing chronic lymphocytic leukemia (CLL) treatment landscape. With the development of many new agents, researchers are now investigating how these agents can be optimized in the clinic.

Share this video  
Similar topics